The SpineAlign VBR is company’s first approved product under CE Mark registration for sale outside the US that was designed for a transpedicular, minimally-invasive approach to vertebral body reconstruction and anterior spinal column support.

SpineAlign Medical also reported that industry veteran, Chris McAuliffe, has joined the company as chief operating officer responsible for global operations and technology commercialization.

Gary Grenter, president and CEO, SpineAlign Medical, said: “We are pleased with the distribution partnership we have with ab medica. ab medica has earned the reputation as a premier distribution organization, led by experienced and dynamic leadership in many medical disciplines, including spine and orthopedics.

“Their specialty is the introduction and market development of new and innovative technologies. We regard our professional relationship as a true partnership in which each party has committed significant investments to bring our unique technology to clinicians and spine specialists to improve treatment outcomes in vertebral fracture management.”